What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (mis)interpretation

Nick Freemantle; Hege Urdahl; Joanne Eastaugh; F D Richard Hobbs

doi:10.1053/pcad.2002.31586

What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (mis)interpretation

Prog Cardiovasc Dis. 2002 Jan-Feb;44(4):243-50. doi: 10.1053/pcad.2002.31586.

Authors

Nick Freemantle¹, Hege Urdahl, Joanne Eastaugh, F D Richard Hobbs

Affiliation

¹ Department of Primary Care and General Practice, School of Medicine, University of Birmingham, Edgbaston, UK.

PMID: 12007080
DOI: 10.1053/pcad.2002.31586

Abstract

Beta blockers have long been used in patients who have experienced a myocardial infarction. However, many new therapies are available for this patient group, and as a result, the current role of beta blockers may have become uncertain. In this article we address a series of questions related to the important and continuing role of beta blockade after myocardial infarction.

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Humans
Myocardial Infarction / drug therapy*
Randomized Controlled Trials as Topic

Substances

Adrenergic beta-Antagonists